Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 2
2009 4
2010 1
2011 2
2012 2
2013 3
2014 2
2015 2
2016 1
2017 3
2018 3
2019 3
2020 3
2021 2
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
Eichhorst B, Niemann CU, Kater AP, Fürstenau M, von Tresckow J, Zhang C, Robrecht S, Gregor M, Juliusson G, Thornton P, Staber PB, Tadmor T, Lindström V, da Cunha-Bang C, Schneider C, Poulsen CB, Illmer T, Schöttker B, Nösslinger T, Janssens A, Christiansen I, Baumann M, Frederiksen H, van der Klift M, Jäger U, Leys MBL, Hoogendoorn M, Lotfi K, Hebart H, Gaska T, Koene H, Enggaard L, Goede J, Regelink JC, Widmer A, Simon F, De Silva N, Fink AM, Bahlo J, Fischer K, Wendtner CM, Kreuzer KA, Ritgen M, Brüggemann M, Tausch E, Levin MD, van Oers M, Geisler C, Stilgenbauer S, Hallek M; GCLLSG, the HOVON and Nordic CLL Study Groups, the SAKK, the Israeli CLL Association, and Cancer Trials Ireland. Eichhorst B, et al. N Engl J Med. 2023 May 11;388(19):1739-1754. doi: 10.1056/NEJMoa2213093. N Engl J Med. 2023. PMID: 37163621 Clinical Trial.
Das Myelodysplastische Syndrom.
Benz R. Benz R. Ther Umsch. 2022;79(2):69. doi: 10.1024/0040-5930/a001330. Ther Umsch. 2022. PMID: 35291850 Free article. German. No abstract available.
Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine.
Chanias I, Stojkov K, Stehle GT, Daskalakis M, Simeunovic H, Njue LM, Schnegg-Kaufmann AS, Porret NA, Allam R, Rao TN, Benz R, Ruefer A, Schmidt A, Adler M, Rovo A, Balabanov S, Stuessi G, Bacher U, Bonadies N, On Behalf Of The Swiss Mds Study Group. Chanias I, et al. Among authors: benz r. Cancers (Basel). 2021 Jun 30;13(13):3296. doi: 10.3390/cancers13133296. Cancers (Basel). 2021. PMID: 34209457 Free PMC article. Review.
CALR loss-of-heterozygosity as a potential driver for extramedullary AML.
Weller MC, Haralambieva E, Bühler MM, Benz R, Theocharides APA, Balabanov S. Weller MC, et al. Among authors: benz r. Ann Hematol. 2022 Nov;101(11):2571-2573. doi: 10.1007/s00277-022-04976-8. Epub 2022 Sep 26. Ann Hematol. 2022. PMID: 36155839 No abstract available.
Lots of clots and rods.
Benz R, Gerber B. Benz R, et al. Br J Haematol. 2014 Jun;165(6):744. doi: 10.1111/bjh.12807. Epub 2014 Mar 2. Br J Haematol. 2014. PMID: 24580077 Free article. No abstract available.
Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q).
Rüfer A, Angermann H, Benz R, Bonadies N, Calderoni A, Cantoni N, Efthymiou A, Escher R, Favre G, Friess D, Gschwend A, Himmelmann A, Holbro A, Keller P, Kouroupi E, Lehmann T, Pedarnig N, Rigamonti V, Samii K, Schmidt A, Schäfer HP, Sperb R, Stüssi G, Winkler A, Zenhäusern R, Goede JS. Rüfer A, et al. Among authors: benz r. Hemasphere. 2022 Jun 17;6(7):e741. doi: 10.1097/HS9.0000000000000741. eCollection 2022 Jul. Hemasphere. 2022. PMID: 35747588 Free PMC article. No abstract available.
Double hit, triple hit--look for it.
Benz R, Tchinda J. Benz R, et al. Blood. 2013 Mar 28;121(13):2383. doi: 10.1182/blood-2012-10-451716. Blood. 2013. PMID: 23658934 Free article. No abstract available.
Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium.
Rovó A, Cantoni N, Samii K, Rüfer A, Koenen G, Ivic S, Cavanna D, Benz R. Rovó A, et al. Among authors: benz r. PLoS One. 2022 Apr 21;17(4):e0267342. doi: 10.1371/journal.pone.0267342. eCollection 2022. PLoS One. 2022. PMID: 35446925 Free PMC article.
37 results